company background image
LASA logo

Lasa Supergenerics NSEI:LASA Stock Report

Last Price

₹22.00

Market Cap

₹1.1b

7D

-4.3%

1Y

21.5%

Updated

28 Mar, 2024

Data

Company Financials

Lasa Supergenerics Limited

NSEI:LASA Stock Report

Market Cap: ₹1.1b

LASA Stock Overview

Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products primarily in India.

LASA fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends1/6

Lasa Supergenerics Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Lasa Supergenerics
Historical stock prices
Current Share Price₹22.00
52 Week High₹41.20
52 Week Low₹18.05
Beta0.56
1 Month Change-27.75%
3 Month Change-26.42%
1 Year Change21.55%
3 Year Change-63.58%
5 Year Change-10.20%
Change since IPO-85.05%

Recent News & Updates

Little Excitement Around Lasa Supergenerics Limited's (NSE:LASA) Revenues As Shares Take 26% Pounding

Mar 13
Little Excitement Around Lasa Supergenerics Limited's (NSE:LASA) Revenues As Shares Take 26% Pounding

Improved Revenues Required Before Lasa Supergenerics Limited (NSE:LASA) Stock's 25% Jump Looks Justified

Dec 28
Improved Revenues Required Before Lasa Supergenerics Limited (NSE:LASA) Stock's 25% Jump Looks Justified

Recent updates

Little Excitement Around Lasa Supergenerics Limited's (NSE:LASA) Revenues As Shares Take 26% Pounding

Mar 13
Little Excitement Around Lasa Supergenerics Limited's (NSE:LASA) Revenues As Shares Take 26% Pounding

Improved Revenues Required Before Lasa Supergenerics Limited (NSE:LASA) Stock's 25% Jump Looks Justified

Dec 28
Improved Revenues Required Before Lasa Supergenerics Limited (NSE:LASA) Stock's 25% Jump Looks Justified

We Think Lasa Supergenerics (NSE:LASA) Has A Fair Chunk Of Debt

Jul 05
We Think Lasa Supergenerics (NSE:LASA) Has A Fair Chunk Of Debt

Lasa Supergenerics (NSE:LASA) Is Carrying A Fair Bit Of Debt

Mar 28
Lasa Supergenerics (NSE:LASA) Is Carrying A Fair Bit Of Debt

Lasa Supergenerics' (NSE:LASA) Dividend Will Be ₹0.25

Sep 02
Lasa Supergenerics' (NSE:LASA) Dividend Will Be ₹0.25

Would Lasa Supergenerics (NSE:LASA) Be Better Off With Less Debt?

Aug 13
Would Lasa Supergenerics (NSE:LASA) Be Better Off With Less Debt?

A Look At The Fair Value Of Lasa Supergenerics Limited (NSE:LASA)

Jun 21
A Look At The Fair Value Of Lasa Supergenerics Limited (NSE:LASA)

Is Lasa Supergenerics (NSE:LASA) Using Too Much Debt?

Dec 06
Is Lasa Supergenerics (NSE:LASA) Using Too Much Debt?

Shareholder Returns

LASAIN PharmaceuticalsIN Market
7D-4.3%2.7%2.5%
1Y21.5%63.9%47.3%

Return vs Industry: LASA underperformed the Indian Pharmaceuticals industry which returned 63.9% over the past year.

Return vs Market: LASA underperformed the Indian Market which returned 47.3% over the past year.

Price Volatility

Is LASA's price volatile compared to industry and market?
LASA volatility
LASA Average Weekly Movement7.9%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.6%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.0%

Stable Share Price: LASA's share price has been volatile over the past 3 months.

Volatility Over Time: LASA's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
201689Omkar Herlekarhttps://lasalabs.com

Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products primarily in India. It offers API products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, riclabendazole, rafoxanide, ornidazole, ricobendazole, oxfendazole, closantel base, closantel sodium, nitroxynil, halquinol, and oxyclozanide, as well as 2,6-diiodo-4-nitrophenol; and other API products. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use comprising potassium iodide.

Lasa Supergenerics Limited Fundamentals Summary

How do Lasa Supergenerics's earnings and revenue compare to its market cap?
LASA fundamental statistics
Market cap₹1.09b
Earnings (TTM)-₹214.42m
Revenue (TTM)₹1.17b

0.9x

P/S Ratio

-5.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LASA income statement (TTM)
Revenue₹1.17b
Cost of Revenue₹835.05m
Gross Profit₹333.37m
Other Expenses₹547.79m
Earnings-₹214.42m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-4.28
Gross Margin28.53%
Net Profit Margin-18.35%
Debt/Equity Ratio20.3%

How did LASA perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

n/a

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.